ACE Inhibitors and Angiotensin Receptor Antagonists and the Incidence of New-Onset Diabetes Mellitus David AguilarScott D. Solomon Current Opinion 12 September 2012 Pages: 1169 - 1177
Novel Treatment Options for Inflammatory Bowel Disease Francesco LanzarottoMarta CarpaniSubrata Ghosh Leading Article 12 September 2012 Pages: 1179 - 1189
Pharmacotherapy of Lupus Nephritis in Children Alexa AdamsEmma Jane MacDermottThomas J. A. Lehman Therapy in Practice 12 September 2012 Pages: 1191 - 1207
Pharmacological Therapy for Wegener’s Granulomatosis Eric S. WhiteJoseph P. Lynch III Review Article 12 September 2012 Pages: 1209 - 1228
Pharmacotherapy of Alcoholism in Patients with Co-morbid Psychiatric Disorders Benjamin I. GoldsteinArtemis DiamantourosClaudio A. Naranjo Review Article 12 September 2012 Pages: 1229 - 1237
Desirable Therapeutic Characteristics of an Optimal Antihypertensive Agent Lisa Mustone Alexander Review Article 12 September 2012 Pages: 1239 - 1252
Probiotics for Prevention of Recurrent Urinary Tract Infections in Women Matthew E. FalagasGregoria I. BetsiStavros Athanasiou Review Article 12 September 2012 Pages: 1253 - 1261
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) M. Asif A. SiddiquiCaroline M. Perry Adis Drug Profile 12 September 2012 Pages: 1263 - 1271
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) Daron G. Ferris Adis Drug Profile 12 September 2012 Pages: 1272 - 1272
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) Kenneth H. Fife Adis Drug Profile 12 September 2012 Pages: 1272 - 1272
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) Kevin A. Ault Adis Drug Profile 12 September 2012 Pages: 1272 - 1273
Lopinavir/Ritonavir Vicki OldfieldGreg L. Plosker Adis Drug Evaluation 12 September 2012 Pages: 1275 - 1299